33 related articles for article (PubMed ID: 15635970)
1. Seroprevalence of varicella-zoster virus as measured by fluorescent antibody to membrane antigen assay and glycoprotein enzyme-linked immunosorbent assay more than 10 years after initiation of a universal vaccination program: An observational study.
Ji HS; Kang KR; Kang HM; Choi UY; Lee SY; Kang JH
Medicine (Baltimore); 2024 Jan; 103(3):e36931. PubMed ID: 38241578
[TBL] [Abstract][Full Text] [Related]
2. Has VZV epidemiology changed in Italy? Results of a seroprevalence study.
De Donno A; Kuhdari P; Guido M; Rota MC; Bella A; Brignole G; Lupi S; Idolo A; Stefanati A; Del Manso M; Gabutti G;
Hum Vaccin Immunother; 2017 Feb; 13(2):385-390. PubMed ID: 28027004
[TBL] [Abstract][Full Text] [Related]
3. Modelling the effects of population structure on childhood disease: the case of varicella.
Silhol R; Boëlle PY
PLoS Comput Biol; 2011 Jul; 7(7):e1002105. PubMed ID: 21814504
[TBL] [Abstract][Full Text] [Related]
4. Clinically- versus serologically-identified varicella: A hidden infection burden. A ten-year follow-up from a randomized study in varicella-endemic countries.
Gillard P; Povey M; Carryn S
Hum Vaccin Immunother; 2021 Oct; 17(10):3747-3756. PubMed ID: 34181506
[TBL] [Abstract][Full Text] [Related]
5. Varicella zoster virus transmission dynamics in Vojvodina, Serbia.
Medić S; Katsilieris M; Lozanov-Crvenković Z; Siettos CI; Petrović V; Milošević V; Brkić S; Andrews N; Ubavić M; Anastassopoulou C
PLoS One; 2018; 13(3):e0193838. PubMed ID: 29505590
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data.
Bollaerts K; Riera-Montes M; Heininger U; Hens N; Souverain A; Verstraeten T; Hartwig S
Epidemiol Infect; 2017 Oct; 145(13):2666-2677. PubMed ID: 28826422
[TBL] [Abstract][Full Text] [Related]
7. Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya.
Nyiro JU; Kombe IK; Sande CJ; Kipkoech J; Kiyuka PK; Onyango CO; Munywoki PK; Kinyanjui TM; Nokes DJ
PLoS One; 2017; 12(5):e0177803. PubMed ID: 28531224
[TBL] [Abstract][Full Text] [Related]
8. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.
Riera-Montes M; Bollaerts K; Heininger U; Hens N; Gabutti G; Gil A; Nozad B; Mirinaviciute G; Flem E; Souverain A; Verstraeten T; Hartwig S
BMC Infect Dis; 2017 May; 17(1):353. PubMed ID: 28521810
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.
van Rijckevorsel GG; Damen M; Sonder GJ; van der Loeff MF; van den Hoek A
BMC Infect Dis; 2012 Jun; 12():140. PubMed ID: 22721551
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.
Djawe K; Daly KR; Vargas SL; Santolaya ME; Ponce CA; Bustamante R; Koch J; Levin L; Walzer PD
Int J Infect Dis; 2010 Dec; 14(12):e1060-6. PubMed ID: 20926326
[TBL] [Abstract][Full Text] [Related]
11. Varicella susceptibility and transmission dynamics in Slovenia.
Socan M; Berginc N; Lajovic J
BMC Public Health; 2010 Jun; 10():360. PubMed ID: 20573202
[TBL] [Abstract][Full Text] [Related]
12. Varicella vaccination in Europe - taking the practical approach.
Bonanni P; Breuer J; Gershon A; Gershon M; Hryniewicz W; Papaevangelou V; Rentier B; Rümke H; Sadzot-Delvaux C; Senterre J; Weil-Olivier C; Wutzler P
BMC Med; 2009 May; 7():26. PubMed ID: 19476611
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of Varicella Zoster Virus infection in Italy.
Gabutti G; Rota MC; Guido M; De Donno A; Bella A; Ciofi degli Atti ML; Crovari P;
BMC Public Health; 2008 Oct; 8():372. PubMed ID: 18954432
[TBL] [Abstract][Full Text] [Related]
14. Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control.
Egger JR; Ooi EE; Kelly DW; Woolhouse ME; Davies CR; Coleman PG
Bull World Health Organ; 2008 Mar; 86(3):187-96. PubMed ID: 18368205
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain).
Salleras L; Domínguez A; Plans P; Costa J; Cardeñosa N; Torner N; Plasència A
Med Microbiol Immunol; 2008 Sep; 197(3):329-33. PubMed ID: 18004592
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population.
Davidovici BB; Balicer RD; Klement E; Green MS; Mendelson E; Smetana Z; Cohen DI
Eur J Epidemiol; 2007; 22(9):641-6. PubMed ID: 17668279
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg.
Mossong J; Putz L; Patiny S; Schneider F
Epidemiol Infect; 2006 Aug; 134(4):808-13. PubMed ID: 16436219
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg.
Mossong J; Putz L; Schneider F
Epidemiol Infect; 2004 Dec; 132(6):1121-7. PubMed ID: 15635970
[TBL] [Abstract][Full Text] [Related]
19. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
